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Multiple sclerosis and herpesvirus interaction
Esclerose múltipla e interação com os herpesvirus
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the etiology of multiple sclerosis
Multiple sclerosis (MS) is the most common autoimmune 
inflammatory disease of the central nervous system (CNS). 
Even though the underlying mechanisms responsible for the 
myelin targeted autoimmune attacks on the CNS have been 
the goal of many studies, a precise etiological agent has yet 
to be defined. MS has many characteristics of an etiologically 
complex disease, including heterogeneity, incomplete pene-
trance, temporal changes, polygenic inheritance, environ-
mental risk factors and genetic predisposition1.
There are two main theories that try to explain MS: the 
genetic and the environmental theories. They interact among 
each other and are very susceptible to individual variations. 
The first theory relies on inherited immune response abnor-
malities while the second discusses exposure to antigens, 
trauma, viral infections, and nutritional disorders, among 
others. 
Two hypotheses seek to justify viral causes as the triggers 
for MS. The first hypothesis suggests that a virus can infect 
an adult, subsequently increasing his or her chance to deve-
lop MS, which wouldn’t happen had the infection taken place 
during childhood. The second hypothesis affirms that trigger 
pathogens would have higher prevalence in areas with higher 
MS prevalence. The common point between the two theories 
is that the age during the first infection determines the popu-
lation’s susceptibility2.
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ABStrACt
Multiple sclerosis is the most common autoimmune inflammatory demyelinating disease of the central nervous system, and its etiology 
is believed to have both genetic and environmental components. Several viruses have already been implicated as triggers and there are 
several studies that implicate members of the Herpesviridae family in the pathogenesis of MS. The most important characteristic of these 
viruses is that they have periods of latency and exacerbations within their biological sanctuary, the central nervous system. The Epstein-Barr, 
cytomegalovirus, human herpesvirus 6 and human herpesvirus 7 viruses are the members that are most studied as being possible triggers 
of multiple sclerosis. According to evidence in the literature, the herpesvirus family is strongly involved in the pathogenesis of this disease, 
but it is unlikely that they are the only component responsible for its development. There are probably multiple triggers and more studies are 
necessary to investigate and define these interactions.
Keywords: demyelinating disease, bmultiple sclerosis, herpesvirus.
rESUMO
A esclerose múltipla é a doença inflamatória auto-imune mais comum do sistema nervoso central. Sua etiologia já foi creditada apresentar 
tanto causas genéticas quanto ambientais. Vários vírus já foram implicados como desencadeadores desta doença e existem inúmeros traba-
lhos fazendo correlação entre a família Herpesviridae e a patogênese da esclerose múltipla. As características mais importantes dos Herpes-
viridae são as de apresentarem períodos de latência e exacerbação e terem como seu principal santuário biológico o sistema nervoso central. 
O vírus Epstein-Barr, o citomegalovírus, o herpesvirus tipo 6 e herpesvirus tipo 7 são os membros mais estudados como desencadeadores da 
esclerose múltipla. Conforme as evidencias que a literatura apresenta a família Herpesviridae está fortemente envolvida na patogênese da 
esclerose múltipla, porém é pouco provável que sejam os únicos responsáveis pelo seu início. É provável que esta doença apresente inúme-
ros desencadeadores e mais estudos são necessários para determinar estas interações.
Palavras-Chave: doença desmielinizante, esclerose múltipla, herpesvírus. 
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In addition, there are other observations that point to a 
viral etiology in MS: 1) many viruses are associated with en-
cephalomyelitis and other demyelinating processes; 2) axo-
nal damage, usually associated with CNS viral infections, can 
precede MS lesions; 3) the T CD8 lymphocytes, involved in 
viral immunity, are the predominating lymphocytes in the 
active demyelinating plaques; 4) cortical and axonal damage 
in the absence of lesions, which are features observed in viral 
demyelinating processes, are commonly seen in MS; 5) some 
viruses, including the herpesvirus, have periods of latency and 
reactivation that resemble the relapsing remitting MS pattern3.
Members of the Herpesviridae family, like the Epstein-
Barr Virus (EBV), Human Herpes Virus 6 and 7 (HHV-6 and 
HHV-7) and Cytomegalovirus (CMV) are among the plausi-
ble viral agents. Endogenous retroviruses should also be con-
sidered as important viral agents in MS.
the Herpesviridae family
The Herpesviridae family is composed of 8 types of agents, 
each divided into 3 subfamilies (alpha, beta and gamma). All 
herpesviruses have 3 basic structural elements: 1- a symme-
tric nucleocapsid with a diameter of 90 to 110 nm in the form 
of an icosahedron which contains the viral DNA, 2- an enve-
lope embedding the viral glycoproteins and 3- the viral tegu-
ment consisting of a mix of proteins that occupy the space 
between the nucleocapsid and the envelope4.
The herpesviridae are capable of staying dormant in the 
host’s organism after first infection due to a latency state in 
which there is no viral replication or in a state of chronic low 
level replication. It’s important to note that each of these re-
plication states will occur in different sites in the body of the 
host. While the salivary glands and brain tissue are consi-
dered sites of chronic replication, monocytes and bone mar-
row are considered sites where there is virus latency. It is a 
very important fact that one of the herpesviridae biological 
sanctuaries is the CNS3.
Epstein Barr virus and MS
Certainly the most important herpesvirus related to MS 
is the EBV. The relation between positive serology to EBV and 
MS development has been extensively studied. In addition, 
the effects of EBV within the immune system are undeniable 
because it maintains a persistent immune response and im-
mortalizes lymphocytes (to a certain point). There have also 
been a few studies that correlate EBV expression with major 
MS activity. Finally, the interaction between EBV and endoge-
nous retrovirus has been a recent fascinating field of study. 
The EBV was the first virus from the Herpesviridae to be 
implicated as a possible trigger for MS, in 1971. By that time 
EBV was a candidate due to some factors: is widely distri-
buted in the nature, establishes a long quiescent infection 
with continuous viral production, with long periods of reactiva-
tion and is capable of modulating the human immune system.
EBV serology and MS development
The major difficulty in associating MS to the EBV is prov-
ing that the infection comes prior to the autoimmune disea-
se. Studying MS pediatric populations was a way to reduce 
this bias. Pohl et al. presented a study with 147 pediatric MS 
patients in Europe where the serum prevalence of EBV was of 
99%, in comparison with 72% in the control group (p=0.001)5.
Levin et al. estimated the viral infection time through 
measures of antibody titers of EBV in serial serum samples 
collected before MS onset among cases, and on matched 
dates among controls. They had access to the medical his-
tory of approximately 8 million USA Army employees whose 
blood samples were stored. The case-control study had 305 
people that came to develop MS comprising the study group 
and 610 people comprising the paired control group. Ten in-
dividuals from the study group and 32 from the control group 
were EBV-negative at the beginning. Everyone from the EBV-
negative cases of the study group (100% of the cases) became 
EBV-positive before the onset of MS in comparison to only 
35.7% in the control group (p=0.0008)6.
Other research projects also tried to evaluate the relation-
ship between EBV antibodies serum titers and the onset of 
MS. According to the work of DeLorenze et al., patients with 
MS already showed a significant elevation of EBV antibodies 
20 years before the onset of the first symptoms. It is possible to 
explain this data in two ways: by the previous existence of an 
infection that alters the balance of the EBV related T memory 
cells or by a re-infection caused by a different strain of EBV7.
The EBV targeted T lymphocyte response sets up  
and maintains MS 
EBV can infect the B lymphocytes in a very persistent 
and highly immunogenic way. The T lymphocyte specific an-
tigens are continually produced in increased amounts in res-
ponse to the first infection and to the chronically high levels 
of the virus. This autoimmune control is essential to prevent 
EBV related neoplasm. In its modulating action it is capable 
of recruiting infected B lymphocytes via expression of latent 
antigens and helps their differentiation into B memory cells, 
where the virus persists8.
In chronic EBV infections there are strong stimuli to EBV-
specific T lymphocytes. When grown in vitro these cells 
suppress the production of immunoglobulins by the B cells. 
Some studies show that patients with autoimmune disea-
ses might have defects in the EBV-specific immunity, such as 
having a tendency to produce ten times more lysate stimula-
ting interferon.
However it has not been proven if the increase in EBV-
specific T CD4 cells is a response to an increase in stimula-
tion by specific myelin antigens identification. The EBV viral 
load in MS is not very high and the specific T cells for this 
virus do not seem to be differentiated from the same cells in 
hosts without MS9.
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EBV expression is correlated with major MS activity
During the MS reactivation period there is an increased 
viral replication period in comparison to the remission pe-
riod. Patients with early antibody response to EBV antigen 
are more susceptible to show disease activity, measured 
through gadolinium nuclear magnetic resonance, than those 
patients without humoral response. Because of this the di-
sease activity may be related to a latent EBV infection and 
also is associated with the progression of the disease10.
EBV and endogenous retroviruses as emergent associated 
viruses contributing to MS pathogenesis
About 8% of the human genome is constituted by endo-
genous retroviruses and those have been implicated in 
many diseases. The activity increase of these viruses may 
be observed in MS patients. The endogenous retroviruses 
of the W family was isolated in the leptomeninges, cho-
roid plexus and cultures of monocytes/macrophages in 
patients with multiple sclerosis and their origin is still un-
der investigation11-14. Our group has recently published the 
first Brazilian study about the association between MS and 
Endogenous retrovirus with similar results15. The oligoden-
drocytes are responsible for the myelin production of the 
central nervous system and can be more sensitive to the en-
dogenous retrovirus than the astrocytes on an animal mo-
del that mimics MS16. 
A recent study conducted in Sassary, Italy has shown 
that, in vitro, EBV stimulates the expression of HERV-W in 
cells deriving from blood and brain. They suggest that in MS 
pathogenesis, a possible model could include EBV as the ini-
tial trigger of future MS, years later, and HERV-W as an actual 
contributor to MS pathogenicity, in striking parallelism with 
disease behavior17.
Cytomegalovirus and multiple sclerosis
Studies that correlate levels of antibodies against CMV 
and MS are controversial. Studies show high rates of CMV 
infectivity in patients with MS but also a more benign pre-
sentation of the disease. Sana dgol et al. collected serum, plas-
ma, peripheral blood mononuclear cells (PBMCs), saliva and 
urine from MS patients (n=78) and healthy subjects (n=123) 
and screened for the presence of anti-CMV antibodies and 
CMV-DNA by nephelometric and PCR methods. Positive 
results for CMV antibodies were found in 98% of MS pa-
tients compared with 52% in the control group (p<0.001)18. 
Zivadinov demonstrated that patients who had antibody 
against CMV had later age of onset, lower rates of reactiva-
tion of the disease, and fewer signs of cerebral atrophy on 
MRI. Those who had higher titers of these antibodies had 
less brain atrophy and fewer lesions on imaging stu dies, 
when compared with patients who had lower titers19. Pirko 
et al., using an animal model to mimic the patterns of MS, 
demonstrated that animals that had CMV infection before a 
de myelinating induced disease had milder clinical presenta-
tions than those not infected20. These studies suggest a ben-
eficial effect of CMV infection by immune response modula-
tion during MS.
Herpes virus type 6 and 7 and multiple sclerosis
HHV-6 and HHV-7 viruses are closely related and have a 
similar biologic pattern. These viruses can infect cells of the 
immune system and modulate their functions. The work des-
cribed by Nora-Krukle et al. attempted to investigate whe-
ther there were associations between HHV-6 and HHV-7 in 
MS by analyzing the peripheral blood of patients. Patients 
were randomly selected and divided into two groups: 14 with 
relapsing remitting multiple sclerosis (RR-MS) and 14 with 
secondary progressive multiple sclerosis (SP-MS). Among the 
28 patients, 25 had latent HHV-6 and/or HHV-7. HHV-6 has 
been found in 9 patients with RR-MS and 9 with the SP-MS. 
HHV-7 was found in 10 patients with RR-MS and 14 with the 
SP-MS21. 
Opsahl and Kennedy, through the technique of in situ 
fluorescence hybridization, examined tissues from human 
cadavers to assess the presence of recent and old HHV-6 
viral gene expression in normal brain white matter of MS 
patients, injured tissue of patients with MS and brain sam-
ples of a control group without the disease. The gene trans-
cription of HHV-6 was found in all samples analyzed and 
was restricted to oligodendrocytes. Quantitative analy-
sis of viral RNA expression showed that in both groups of 
pa tients with MS (no brain tissue with abnormal white 
matter), samples had significantly higher levels of expres-
sion of this virus. Furthermore, the tissue lesions pre-
sented higher levels of expression of the viral gene, a fact 
that contributes to the theory that HHV-6 is implicated 
in the pathogenesis of MS22. The same study methodolo-
gy using HHV-7 showed no difference between groups23. 
Using all these virus research methods repeatedly, con-
flicting results can be observed. In fact, when the technolo-
gies used were unable to distinguish an active from a latent 
HHV-6 infection (via analysis of blood leukocytes by PCR and 
cell liquor containing central nervous system tissue), no dif-
ference is found among the samples from patients and con-
trol groups. However, when diagnostic technologies are used 
specifically for detecting the activity of HHV-6 (PCR analysis 
of acellular specimens, detection of specific IgM antibodies 
to HHV-6 or immunohistochemical analysis of tissues of the 
central nervous system), a strong correlation between HHV-6 
and pathogenesis of MS is observed24. However, it is impor-
tant emphasize that HHV-7 has little evidence supporting its 
correlation MS.
Conclusion
Undoubtedly, MS is an extremely complex disease. The 
heterogeneity of symptoms, its multiple presentations and 
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its patterns of symptoms are highly variable from person to 
person. This enormous variation is the reason why some pa-
tients are already much debilitated in the beginning of the 
disease while others keep living their lives normally. 
Apart from its vast spectrum of symptoms this disease is 
of utter importance due to its imense socioeconomic impact. 
The etiology of MS has been thoroughly studied yet not one 
single etiology has been defined. A viral trigger was suggested 
over 100 years ago and, since then, several viruses have been 
appointed as possible candidates.
The main hypothesis is that there is no isolated factor as a 
cause for MS but a myriad of them acting together and in dif-
ferent ways on each individual, associated with genetic sus-
ceptibility. More studies are needed in an attempt to confirm 
this hypothesis and permit possible interventions that may 
minimize the effects of such interactions.
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